| 書(shū)目名稱 | New Developments in Antirheumatic Therapy |
| 編輯 | K. D. Rainsford,G. P. Velo |
| 視頻video | http://file.papertrans.cn/665/664996/664996.mp4 |
| 叢書(shū)名稱 | Inflammation and Drug Therapy Series |
| 圖書(shū)封面 |  |
| 描述 | At present we may be at the cross-roads in the therapeutic approaches we have for the treatment of the 100 or more rheumatic conditions. This is be- cause we now recognise that although some advances have been made with the development of a large range of non-steroidal and steroidal drugs during the past two decades or so, we now recognise that many, if not all, of these have rather limited effects on many of the disease processes which underlie the manifestations of the various rheumatic states. Advances in molecular bi- 010gy in the past 5-10 years have enabled these tools to be applied extensive- ly for developing further our understanding of the rheumatic disease processes. In some cases these molecular tools (e. g. ,),-interferon, interleukin- 2, T-cell antibodies) have been directly employed as therapies themselves. While the outcome from trials with such agents in rheumatoid arthritis in particular has not been as would have been hoped, these results as with cy- closporin A and low-dose methotrexate in the therapy of rheumatoid arth- ritis have given us important indications for the approach employing what are generally described as "immunomodulators" to control this disease |
| 出版日期 | Book 1989 |
| 關(guān)鍵詞 | Arthritis; drug; drug development; inflammation; osteoarthritis; research; rheumatoid arthritis; toxicity |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-94-009-1253-3 |
| isbn_softcover | 978-94-010-7056-0 |
| isbn_ebook | 978-94-009-1253-3Series ISSN 0923-9405 |
| issn_series | 0923-9405 |
| copyright | Kluwer Academic Publishers 1989 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 05:33
發(fā)表于 2025-3-21 16:50:16
